Investigation of the antitumor activity and toxicity of cisplatin loaded pH-sensitive-pegylated liposomes in a triple negative breast cancer animal model-Reference-Cited by-同舟云学术

Investigation of the antitumor activity and toxicity of cisplatin loaded pH-sensitive-pegylated liposomes in a triple negative breast cancer animal model

Published:2021-04 Issue: Volume:62 Page:102400
ISSN:1773-2247
Container-title:Journal of Drug Delivery Science and Technology
language:en
Short-container-title:Journal of Drug Delivery Science and Technology

Author:

Franco Marina Santiago^ORCID,Silva Camila Alves,Leite Elaine Amaral,Silveira Josianne Nicácio,Teixeira Cláudia Salviano,Cardoso Valbert Nascimento,Ferreira Enio,Cassali Geovanni Dantas,Branco de Barros André Luís,Oliveira Mônica Cristina

Funder

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Fundação de Amparo à Pesquisa do Estado de Minas Gerais

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference36 articles.

1. Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects;Florea;Cancers,2011

2. Cisplatin in cancer therapy: molecular mechanisms of action;Shaloam;Eur. J. Pharmacol.,2014

3. Molecular alterations in triple-negative breast cancer—the road to new treatment strategies;Denkert;Lancet,2017

4. Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial;Von Minckwitz;Lancet Oncol.,2014

5. Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (A;Sikov;J. Clin. Oncol.,2015

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review on Stimuli-pH responsive liposomal formulation in cancer therapy;Journal of Drug Delivery Science and Technology;2023-12

2. Cytotoxic Effects of Nanoliposomal Cisplatin and Diallyl Disulfide on Breast Cancer and Lung Cancer Cell Lines;Biomedicines;2023-03-27

3. Hybrid protein-polymer nanoparticles based on P(NVCL-co-DMAEMA) loaded with cisplatin as a potential anti-cancer agent;Journal of Drug Delivery Science and Technology;2023-01

4. Nano to rescue: repository of nanocarriers for targeted drug delivery to curb breast cancer;3 Biotech;2022-02-13

5. pH-responsive and folate-coated liposomes encapsulating irinotecan as an alternative to improve efficacy of colorectal cancer treatment;Biomedicine & Pharmacotherapy;2021-12